Law firm says PROCEPT BioRobotics investors face Sept. 22 lead plaintiff deadline
A law firm says it is notifying investors about a securities fraud class action involving PROCEPT BioRobotics Corp. and has set a Sept. 22, 2026, lead plaintiff deadline.
A law firm says it is notifying investors about a securities fraud class action involving PROCEPT BioRobotics Corporation, or PRCT, and has set a Sept. 22, 2026, deadline for investors seeking lead plaintiff status.
The notice says the complaint covers alleged misconduct between Feb. 28, 2024, and Feb. 25, 2026.
What the notice alleges
The Aug. 14, 2026, release from The Law Offices of Frank R. Cruz says the complaint accuses defendants of making materially false and/or misleading statements about PROCEPT BioRobotics' business, operations and financial condition.
It says the allegations include an extensive discount program used to push bulk handpiece orders beyond procedure demand. The release says that program allegedly inflated reported U.S. handpiece unit sales and revenue by pulling forward sales from future periods.
The notice also says customer orders allegedly exceeded underlying procedure demand throughout the class period, and that the gap widened over time. It says the company's surplus handpiece sales allegedly led to excess field inventory and customer overstocking, totaling more than 10,000 excess units by the end of the class period.
What the law firm said
According to the notice, those conditions allegedly caused PROCEPT BioRobotics to overstate handpiece unit sales and field system utilization while leaving the company exposed to undisclosed operational and financial harm. The release does not provide external verification of the claims, and it does not include a court filing number or venue in the text provided.
The press release says investors who suffered losses may seek to participate in the lawsuit and may retain counsel or remain absent class members. It also says no action is required now for people who qualify as class members.
What happens next
The next stated date in the notice is Sept. 22, 2026, the deadline for investors seeking to be appointed lead plaintiff. The release does not say when a court may rule on that request.
Sources
Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.
View the Web StoryA visual, tap-through version of this reportThis is the AMP version of the article. Read the full article on Atlas Watchline.